Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

13,802 total articles

Buying the Xiaomi Ecosystem Reboot: Betting on $29B in R&D to Drive Higher-Margin Hardware and Services

Buying the Xiaomi Ecosystem Reboot: Betting on $29B in R&D to Drive Higher-Margin Hardware and Services

Xiaomi's announced $29 billion R&D commitment is the strategic lever we want to own. The spend should accelerate product differentiation across smartphones, smart home, and autos, increase software and services monetization, and compress the valuation gap versus better-known consumer-tech peers. We outline a long trade with entry, target and stop, …

Meta After the $18B Deal: Cleaned-Up Balance Sheet, Clearer Growth Path

Meta After the $18B Deal: Cleaned-Up Balance Sheet, Clearer Growth Path

Meta's reported $18 billion settlement is a large headline number, but on the company's scale it is manageable and removes a multi-year legal overhang. With $40.98B in free cash flow, a $1.45T market cap, and a mid-20s PE, the risk-reward favors buying a core position for a 180 trading-day horizon while keeping a disciplined stop at the 52-week low…

Nvidia Is Building an AI Nation-State: Trade Plan to Ride the Next Wave

Nvidia Is Building an AI Nation-State: Trade Plan to Ride the Next Wave

NVIDIA reported record Q2 revenue of $96.2B and Data Center revenue of $89.0B, with guidance implying continued hypergrowth. The company is effectively “nation-building” the AI stack through massive supply commitments and cloud partnerships. This trade idea outlines a disciplined long entry at $228.05, a $320 target over the next 180 trading days, …

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Biohaven shares trade near $15.90 after a pullback; a recently announced Opakalim licensing deal for epilepsy (terms limited) plus multiple 2026 clinical readouts and a still-meaningful cash position support a mid-term, catalyst-driven long. Market cap (~$2.4B), negative EPS (-$4.29), and steep cash burn keep this as a high-risk trade with clearly …

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile remains the most aggressive and efficient U.S. wireless operator: double-digit service revenue growth, strong free cash flow, a 2.2% yield and an attractive EV/EBITDA multiple. After Q2 volatility and a near-term ex-dividend, the stock offers a defined-risk entry for a mid-term swing trade targeting a re-rating toward prior trading ranges.